YKL-40 is associated with disease activity in early rheumatoid arthritis treated with a combination of DMARDs and infliximab

  • Vuolteenaho, K. (Contributor)
  • Markku Kauppi (Contributor)
  • Eeva Moilanen (Contributor)
  • Riina Nieminen (Contributor)

    Activity: Talk or presentationConference presentation

    Description

    Contributors: Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E on behalf of the NEO-RACo Study Group / 8th Science Day of the Kauppi Campus, Tampere, Finland, February 11th, 2016
    Period11 Feb 2016
    Event title8th Science Day of the Kauppi Campus
    Event typeOther
    Degree of RecognitionNational